Contribution of aldehyde oxidizing enzymes on the metabolism of 3,4-dimethoxy-2-phenylethylamine to 3,4-dimethoxyphenylacetic acid by guinea pig liver slices

Cellular Physiology and Biochemistry

Volumn 17, Issue 1-2, 2006, Pages 47-56

  Panoutsopoulos, Georgios I ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

3,4 Dimethoxy 2 phenylethylamine; Aldehyde dehydrogenase; Aldehyde oxidase; Allopurinol; Disulfiram; Homoveratrylamine; Isovanillin; Liver slices; Monoamine oxidase; Xanthine oxidase

Indexed keywords

3,4 DIMETHOXY 2 PHENYLETHYLAMINE; 3,4 DIMETHOXYPHENYLACETIC ACID; ALDEHYDE; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE INHIBITOR; ALDEHYDE OXIDASE; ALLOPURINOL; AMINE OXIDASE (FLAVIN CONTAINING); DISULFIRAM; ENZYME INHIBITOR; ISOVANILLIN; OXIDOREDUCTASE; UNCLASSIFIED DRUG; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME ANALYSIS; ENZYME METABOLISM; FEMALE; GUINEA PIG; INCUBATION TIME; LIVER SLICE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CAVIA PORCELLUS;

EID: 33644955261     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091463     Document Type: Article

References (31)

1. Shih JC, Chen K, Ridd MJ: Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 1999;22:197-217.
2. Panoutsopoulos GI, Kouretas D, Gounaris EG, Beedham C: Enzymatic oxidation of 2-phenylethylamine to phenylacetic acid and 2-phenylethanol with special reference to the metabolism of its intermediate phenylacetaldehyde. Basic Clin Pharmacol Toxicol 2004;95:273-279.
3. Panoutsopoulos GI: Metabolism of homovanillamine to homovanillic acid in guinea pig liver slices. Cell Physiol Biochem 2005;15:225-232.
4. Strolin-Benedetti M: Biotransformation of xenobiotics by amine oxidases. Fundam Clin Pharmacol 2001;15:75-84.
5. Bach AWJ, Lan NC, Johnson DL, Abell CW, Bembenek ME, Kwan SW, Seeburg PH, Shih JC: cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci U.S.A. 1988;85:4934-4938.
6. Tabakoff B, Anderson R, Alivisatos SGA: Enzymic reduction of "biogenic" aldehydes in brain. Mol Pharmacol 1973;9:428-437.
7. Pettersson H, Tottmar O: Inhibition of aldehyde dehydrogenases in rat brain and liver by disulfiram and coprine. J Neurochem 1982;39:628-634.
8. Panoutsopoulos GI, Beedham C: Metabolism of isovanillin by aldehyde oxidase, xanthine oxidase, aldehyde dehydrogenase and liver slices. Pharmacology 2005;73:199-208.
9. Panoutsopoulos GI: Metabolism of 2-phenylethylamine to phenylacetic acid, via the intermediate phenylacetaldehyde, by freshly prepared and cryopreserved guinea pig liver slices. In Vivo 2004;18:779-786.
10. Panoutsopoulos GI, Beedham C: Kinetics and specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase towards substituted benzaldehydes. Acta Biochim Polon 2004;51:649-663.
11. Panoutsopoulos GI, Beedham C: Enzymatic oxidation of vanillin, isovanillin and protocatechuic aldehyde with freshly prepared guinea pig liver slices. Cell Physiol Biochem 2005;15:89-98.
12. Panoutsopoulos GI, Kouretas D, Beedham C: Contribution of aldehyde oxidase, xanthine oxidase and aldehyde dehydrogenase on the oxidation of aromatic aldehydes. Chem Res Toxicol 2004;17:1368-1376.
13. Klyosov AA: Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes. Biochemistry 1996;35:4457-4467.
14. Allali-Hassani A, Weiner H: Interaction of human aldehyde dehydrogenase with aromatic substrates and ligands. Chem Biol Interact 2001;130-132:125-133.
15. Beedham C, Critchley DJP, Ranee DJ: Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit and baboon. Arch Biochem Biophys 1995;319:481-490.
16. Panoutsopoulos GI, Beedham C: Enzymatic oxidation of phthalazine with guinea pig liver aldehyde oxidase and liver slices: Inhibition by isovanillin. Acta Biochim Polon 2004;51:943-951.
17. Morpeth F: Studies on the specificity towards aldehyde substrates and steady-state kinetics of xanthine oxidase. Biochim Biophys Acta 1983;744:328-333.
18. Houslay MD, Tipton KF: A kinetic evaluation of monoamine oxidase activity in the rat liver mitochondrial outer membranes. Biochem J 1974;139:645-652.
19. Peterson GM, Boyle RR, Francis HW, Oliver NWJ, Paterson J, von Witt RJ, Taylor GR: Dosage prescribing and plasma oxipurinol levels in patients receiving allopurinol therapy. Eur J Clin Pharmacol 1990;39:419-421.
20. Deitrich RA, Erwin VG: Mechanism of the inhibition of aldehyde dehydrogenase in vivo by disulfiram and diethyldithiocarbamate. Mol Pharmacol 1971;7:301-307.
21. Lipsky JJ, Shen ML, Naylor S: Overview-In vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolites. Chem Biol Interact 2001;130-132:81-91.
22. Beedham C, Bruce SE, Critchley DJ, Al-Tayib Y, Rance DJ: Species variation in hepatic aldehyde oxidase activity. Eur J Drug Metab Pharmacokinet 1987;12:307-310.
23. Beedham C, Bruce SE, Critchley DJ, Rance DJ: 1-Substituted phthalazines as probes of the substrate-binding site of mammalian molybdenum hydroxylases. Biochem Pharmacol 1990;39:1213-1221.
24. Greek Presidential Decree No 160/1991: Protection of animals used for experimental and other scientific purposes in accordance with EU Directive 86/609/EEC of the Council. Governmental Gazette No 64.
25. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
26. Panoutsopoulos GI, Kouretas D, Gounaris EG, Beedham C: Metabolism of 2-phenylethylamine and phenylacetaldehyde by precision-cut guinea pig fresh liver slices. Eur J Drug Metab Pharmacokinet 2004;29:111-118.
27. Panoutsopoulos GI: Phenylacetaldehyde oxidation by freshly prepared and cryopreserved guinea pig liver slices: The role of aldehyde oxidase. Int J Toxicol 2005;24:103-109.
28. De Kanter R, Olinga P, De Jager MH, Merema MT, Meijer DKF, Groothuis GMM: Organ slices as an in vitro test System for drug metabolism in human liver, lung and kidney. Toxicol In Vitro 1999;13:737-744.
29. Lerche-Langrand C, Toutain HJ: Precision-cut liver slices: characteristics and use for in vitro pharmacotoxicology. Toxicology 2000;153:221-253.
30. Parrish AR, Gandolfi AJ, Brendel K: Precision-cut liver slices: applications in pharmacology and toxicology. Life Sci 1995;57:1887-1901.
31. Ekins S: Past, present and future applications of precision-cut liver slices for in vitro xenobiotic metabolism. Drug Metab Rev 1996;28:591-623.